VIM and cancer: In vitro wound-healing assays have shown that disrupting vimentin blocks directional migration and delays wound healing in several different cell types, including mEF [49], primary astrocytes [49], retinal pigment epithelial cells [9] and polyploidal giant cancer cells [51].